Clinical Trials Logo
  1. Home
  2. Ischemia Reperfusion Injury
  3. NCT00184821
  4. Details
NCT00184821 Clinical Trial

Ischemic Injury and Ischemic Preconditioning in Diabetes

Ischemia-Reperfusion Injury Clinical Trial

Official title:
Acute Local Ischemic Preconditioning in Patients With Type 1 Diabetes in Vivo

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00184821
Other study ID # QKF03-diab
Secondary ID 2004.11.022
Status Completed
Phase N/A
First received September 9, 2005
Last updated April 4, 2007
Start date June 2004
Est. completion date May 2005

Study information
Verified date April 2007
Source Radboud University
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Observational

Clinical Trial Summary

In this proof-of-concept study, forearm vulnerability to ischemic exercise is studied in patients with type 1 diabetes mellitus with and without prior ischemic preconditioning (short period of ischemia that protects against subsequent ischemic exercise). Annexin A5 scintigraphy is used to quantify subtle signs of mild and reversible forearm injury that results from ischemic exercise.

The following hypotheses are tested:

1. Patients with type 1 diabetes are not more vulnerable to ischemic injury as compared with previously studied healthy volunteers.

2. Ischemic preconidtioning is still present in patients with type 1 diabetes. Depending on the validity of hypothesis 2, the effect of short pharmacological interventions are studied on vulnerability to forearm ischemia/reperfusion injury in the absence or presence of local forearm ischemic preconditioning.

Description:

All patients will be studied in supine position after an overnight fast, while plasma glucose levels are monitored. In the first 8 patients intravenous insulin is administered as needed, to reach target glucose levels between 5-7 mmol/l. Patients will be subjected to 10 minutes of forearm ischemia (non-dominant arm), combined with handgripping at 50% of maximal force until exhaustion. Upon reperfusion, Tc-99m-HYNIC-Annexin A5 will be injected intravenously. Targeting of annexin A5 to thenar muscle and forearm flexor muscle will be quantified as the percentage difference in radioactivity between experimental and control side. This procedure will be performed twice (randomized cross-over design), with at least 2 week interval, either with or without 10 minutes ischemia followed by 10 minutes of reperfusion prior to ischemic exercise.

Depending on the results of this study, substudies will be performed to study the effect of diazoxide (K-ATP channel opener, may mimic ischemic preconditioning), glibenclamide (K-ATP channel blocker, may inhibit ischemic preconditioning) or adenosine (infusion into brachial artery of non-dominant arm as a substitute for ischemic preconditioning).

Recruitment information / eligibility
Status Completed
Enrollment 20
Est. completion date May 2005
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- type 1 diabetes mellitus

- age 18-50 years

Exclusion Criteria:

- hypertension (systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg

- cardiovascular disease (coronary artery insufficiency,CVA/TIA, peripheral artery disease

- HbA1c > 9%

- Body Mass Index < 25 kg/m2

- Unable to stop co-medication (other than insulin) for 1 week

- Previous exposure to radiation (diagnostic or therapeutic) in the past year

Study Design

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Intervention

Procedure:
• Ischemic preconditioning

• Forearm ischemic exercise

• Annexin A5 scintigraphy

Drug:
• Diazoxide

• glibenclamide

• adenosine

Locations
Country Name City State
Netherlands Clinical Research Centre Nijmegen; Radboud University Nijmegen Medical Centre Nijmegen Gelderland

Sponsors (2)
Lead Sponsor Collaborator
Radboud University Dutch Diabetes Fund

Country where clinical trial is conducted

Netherlands, 

See also
  Status Clinical Trial Phase
Recruiting NCT05327348 - Effectiveness of IV Vitamin C in Reducing Oxidative Stress Associated With Free Flap Surgery Phase 3
Completed NCT00184912 - The Effect of Caffeine on Ischemic Preconditioning N/A
Recruiting NCT05585255 - Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
Completed NCT05598177 - Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass Phase 4
Completed NCT04284592 - Remote Ischemic Postconditioning Increases HIF-1α Plasma Levels and Improves Cardiac Markers After Cardiac Surgery N/A
Withdrawn NCT00441714 - Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise N/A
Completed NCT00248040 - Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation Phase 2
Completed NCT01486212 - Ischemia-reperfusion Injury Model on Healthy Volunteers and Measurement of Oxidative and Inflammatory Markers N/A
Recruiting NCT06097702 - A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants Phase 1
Completed NCT00224406 - Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation Phase 2
Completed NCT01073202 - Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation N/A
Completed NCT05246618 - FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation Phase 1/Phase 2
Completed NCT02118753 - The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium N/A
Completed NCT01739088 - Pediatric Remote Ischemic Pre-conditioning Prior to Complex Cardiac Surgery N/A
Completed NCT01040013 - Gut Oxygenation and Laparoscopy Phase 2
Suspended NCT00184847 - Adenosine Receptors Influence Ischemia-Reperfusion Injury N/A
Completed NCT01172171 - The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction Phase 2
Completed NCT00457405 - Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury? Phase 4
Not yet recruiting NCT00691613 - Infusion of a Single Dose of Erythropoietin to Prevent Injury in an Ischemia Reperfusion Forearm Model N/A
Completed NCT03818126 - The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement N/A